How do centres begin the process to prevent contrast-induced acute kidney injury: A report from a new regional collaborative

BMJ Quality and Safety

Volumn 21, Issue 1, 2012, Pages 54-62

  Brown, Jeremiah R ^a,b   McCullough, Peter A ^c   Splaine, Mark E ^a,b   Davies, Louise ^d   Ross, Cathy S ^a   Dauerman, Harold L ^e   Robb, John F ^b   Boss, Richard ^f   Goldberg, David J ^g   Fedele, Frank A ^h   Kellett, Mirle A ⁱ   Phillips, William J ^j   Ver Lee, Peter N ^k   Nelson, Eugene C ^a   MacKenzie, Todd A ^b   O'Connor, Gerald T ^a   Sarnak, Mark J ^l   Malenka, David J ^b  

^a DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c St John Providence Health System   (United States)

^d VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f New Hampshire Dartmouth Psychiatric Research Center   (United States)

^g CATHOLIC MEDICAL CENTER   (United States)

^h Portsmouth Regional Hospital   (United States)

ⁱ MAINE MEDICAL CENTER   (United States)

^j CENTRAL MAINE MEDICAL CENTER   (United States)

^k EASTERN MAINE MEDICAL CENTER   (United States)

^l TUFTS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; IOPAMIDOL;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CONTRAST INDUCED NEPHROPATHY; DRUG MEGADOSE; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; LEADERSHIP; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY;

ACUTE KIDNEY INJURY; AGED; CLINICAL PROTOCOLS; CONTRAST MEDIA; FEMALE; HUMANS; INTERINSTITUTIONAL RELATIONS; MALE; MIDDLE AGED; NEW ENGLAND; PATIENT CARE TEAM; PATIENT SAFETY; PROSPECTIVE STUDIES;

EID: 84355163017     PISSN: 20445415     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmjqs-2011-000041     Document Type: Article

References (35)

1. Bui KL, Horner JD, Herts BR, et al. Intravenous iodinated contrast agents: risks and problematic situations. Cleve Clin J Med 2007;74:361-4. 7.
2. Tumlin J, Stacul F, Adam A, et al. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 2006;98:14K-20K.
3. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-75. (Pubitemid 27506242)
4. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-64. (Pubitemid 34535335)
5. Finn WF. The clinical and renal consequences of contrast-induced nephropathy. Nephrol Dial Transplant 2006;21:i2-10.
6. Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:3365-70. (Pubitemid 46179340)
7. National Quality Forum. Safe practices for better healthcare 2006 update: a consensus report. Washington, DC: National Quality Forum, 2007.
8. Elicker BM, Cypel YS, Weinreb JC. IV Contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathy. AJR Am J Roentgenol 2006;186:1651-8. (Pubitemid 46112529)
9. Weisbord SD, Bruns FJ, Saul MI, et al. Provider use of preventive strategies for radiocontrast nephropathy in high-risk patients. Nephron Clin Pract 2004;96:c56-62. (Pubitemid 38456611)
10. Malenka DJ, O'Connor GT. A regional collaborative effort for CQI in cardiovascular disease. Northern New England Cardiovascular Study Group. Jt Comm J Qual Improv 1995;21:627-33.
11. O'Connor GT, Malenka DJ, Quinton H, et al. Multivariate prediction of in-hospital mortality after percutaneous coronary interventions in 1994-1996. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 1999;34:681-91. (Pubitemid 29436172)
12. Mehta RL, Kellum JA, Shah SV, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit care 2007;11:R31. (London, England).
13. Anon. Executive summary-K/DOQI clinical practice guidelines. Am J Kidney Dis 2002;39:S17-31.
14. Best PJ, Reddan DN, Berger PB, et al. Cardiovascular disease and chronic kidney disease: insights and an update. Am Heart J 2004;148:230-42. (Pubitemid 39092788)
15. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;275:1489-94. (Pubitemid 26140761)
16. Corbin JM, Strauss AL. Basics of qualitative research: techniques and procedures for developing grounded theory. 3rd edn. Los Angeles, Calif: Sage Publications, Inc, 2008.
17. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004;291:2328-34. (Pubitemid 38656299)
18. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-20. (Pubitemid 24348355)
19. Maioli M, Toso A, Leoncini M, et al. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 2008;52:599-604.
20. Kunadian V, Zaman A, Spyridopoulos I, et al. Sodium bicarbonate for the prevention of contrast induced nephropathy: a meta-analysis of published clinical trials. Eur J Radiol 2011;79:48-55.
21. Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006;354:2773-82. (Pubitemid 43974195)
22. Trivedi H, Daram S, Szabo A, et al. High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy. Am J Med 2009;122:874 e9-15.
23. Anon. Acetylcystein for the Prevention of Contrast-Induced nephropaThy (ACT) Trial: a pragmatic multicenter randomized trial to evaluate the efficacy of acetylcysteine for the prevention of renal outcomes in patients undergoing coronary and vascular angiography. Circulation 2010;122:2219.
24. Duong MH, MacKenzie TA, Malenka DJ. N-Acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis. Catheter Cardiovasc Interv 2005;64:471-9. (Pubitemid 40463445)
25. Hoffmann U, Fischereder M, Kruger B, et al. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 2004;15:407-10. (Pubitemid 38140781)
26. Rehman T, Fought J, Solomon R. N-Acetylcysteine effect on serum creatinine and cystatin C levels in CKD patients. Clin J Am Soc Nephrol 2008;3:1610-14.
27. Brown JR, Block CA, Malenka DJ, et al. Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis. JACC Cardiovasc Interv 2009;2:1116-24.
28. Call J, Sacrinty M, Applegate R, et al. Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy. J Invasive Cardiol 2006;18:469-74. (Pubitemid 44497336)
29. Brown JR, Robb JF, Malenka DJ. Does 'safe' dosing of iodinated contrast prevent contrast-induced acute kidney injury. Circulation 2009;120:S435.
30. Marenzi G, Assanelli E, Campodonico J, et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 2009;150:170-7.
31. McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 2006;98:5K-13K.
32. Horbar JD. The Vermont-Oxford neonatal network: integrating research and clinical practice to improve the quality of medical care. Semin Perinatol 1995;19:124-31.
33. Likosky DS, Nugent WC, Ross CS. Improving outcomes of cardiac surgery through cooperative efforts: the northern New England experience. Semin Cardiothorac Vasc Anesth 2005;9:119-21. (Pubitemid 40791774)
34. Nugent WC. Building and supporting sustainable improvement in cardiac surgery: the Northern New England experience. Semin Cardiothorac Vasc Anesth 2005;9:115-18. (Pubitemid 40791773)
35. Kasper JF, Plume SK, O'Connor GT. A methodology for QI in the coronary artery bypass grafting procedure involving comparative process analysis. QRB Qual Rev Bull 1992;18:129-33.